Intel is being priced less like an operating company and more like a strategic option on domestic foundry capacity. That distinction matters because non-economic holders can extend the runway, but they do not create ROIC; they often delay the reckoning through more capex, more dilution, and a higher bar for any true equity value creation.

The second-order winner is likely the rest of the semiconductor ecosystem, especially TSMC and high-quality fabless names, if Intel keeps chasing utilization with sub-economic pricing. Revenue growth is not the scarce commodity here; the scarce commodity is proof that external foundry volume can scale faster than depreciation and operating losses. If that mix shift stalls, the market will eventually stop underwriting the story as a quasi-sovereign asset and start valuing it like a capital-intensive manufacturing business.

Near term, the catalyst path is earnings, customer disclosures, and any sign of additional financing or subsidy milestones over the next 1-3 months. Over 6-18 months, the falsifier is visible: external foundry revenue share and operating losses must improve together. If they do not, the current multiple is vulnerable to sharp compression because there is little recurring earnings underneath to anchor it.